GMP Laboratory Data Integrity in 2026: Practical Strategies for FDA and MHRA Inspection Readiness
Why take this course?
GMP laboratory data integrity remains a major inspection focus for FDA and MHRA investigators as laboratories rely more heavily on computerized systems, audit trails, spreadsheets, hybrid workflows, and interconnected data environments. Standard procedures and ALCOA+ training may be in place, yet inspection concerns continue to arise around analyst practices, access management, review quality, oversight effectiveness, and escalation decisions. These issues often signal broader weaknesses in how laboratory data is generated, reviewed, reported, and controlled.
This program focuses on practical inspection readiness for modern GMP laboratories. It examines how investigators interpret laboratory behaviors, identify hidden risk signals, and assess whether oversight practices demonstrate meaningful operational control rather than procedural compliance alone. Attention is given to audit trail review value, spreadsheet and hybrid workflow vulnerabilities, QA oversight, risk prioritization, and sustainable laboratory governance.
Key Areas Covered
Meredith Crabtree
Meredith Crabtree has over 30 years of experience across regulated industries including laboratory, pharmaceutical, medical device, manufacturing, packaging, labeling, and distribution operations. Her work in regulatory assessments, third-party inspections, consent decree support, recall support, and quality training aligns directly with laboratory oversight, inspection readiness, and practical data integrity governance.
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Join the Live Training
4. Watch Again Anytime
Testimonials


